Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 50018549
TargetMuscarinic acetylcholine receptor M3(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50370682(SOLIFENACIN)
Affinity DataEC50:  24nMAssay Description:Antagonist activity at M3 receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50370682(SOLIFENACIN)
Affinity DataIC50: 270nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609447(CHEMBL5284728)
Affinity DataIC50: 340nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609452(CHEMBL5270350)
Affinity DataIC50: 510nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609448(CHEMBL5278585)
Affinity DataIC50: 680nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609449(CHEMBL5290639)
Affinity DataIC50: 690nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609451(CHEMBL5267232)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609467(CHEMBL5288288)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609464(CHEMBL5273870)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609472(CHEMBL5287100)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609461(CHEMBL5268245)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609460(CHEMBL5288534)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609454(CHEMBL5280684)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609469(CHEMBL5285699)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609465(CHEMBL5287033)
Affinity DataIC50: 3.90E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609457(CHEMBL5271222)
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609450(CHEMBL5269880)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609458(CHEMBL5267767)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609459(CHEMBL5279044)
Affinity DataIC50: 5.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609466(CHEMBL5288607)
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609468(CHEMBL5281792)
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609463(CHEMBL5275548)
Affinity DataIC50: 6.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609456(CHEMBL5289822)
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609455(CHEMBL5281603)
Affinity DataIC50: 7.80E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609453(CHEMBL5272819)
Affinity DataIC50: 8.80E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609471(CHEMBL5284190)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609470(CHEMBL5268324)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609447(CHEMBL5284728)
Affinity DataEC50:  1.70E+4nMAssay Description:Antagonist activity at M3 receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Arkuda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50609462(CHEMBL5289562)
Affinity DataIC50: 2.10E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed